Qualigen Theraputics, Inc.
1 clinical trials · Sponsor
◉ Watch Qualigen Theraputics, Inc.
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors (NCT06086522) | Qualigen Theraputics, Inc. | 2023-11-01 |
Track Qualigen Theraputics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.